share_log

CSE Bulletin: Consolidation - PanGenomic Health Inc. (NARA)

newsfile ·  Mar 19 22:56

Toronto, Ontario--(Newsfile Corp. - Le 19 mars/March 2024) - PanGenomic Health Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every ten (10) pre-consolidated common shares.

As a result, the outstanding shares of the company will be reduced to approximately 10,496,746 common shares.

The name and symbol will not change.

Please note that all open orders will be canceled at the close of business on March 20, 2024. Dealers are reminded to re-enter their orders taking into account the share consolidation.

_________________________________

PanGenomic Health Inc. a annoncé une consolidation de ses actions ordinaires émises et en circulation sur la base d'une (1) action ordinaire post-consolidée pour dix (10) actions ordinaires pré-consolidées.

En conséquence, les actions en circulation de la société seront réduites à environ 10 496 746 actions ordinaires.

Le nom et le symbole ne changeront pas.

Veuillez noter que toutes les commandes ouvertes seront annulées à la fermeture des bureaux le 20 mars 2024. Il est rappelé aux concessionnaires de ré-saisir leurs commandes en tenant compte de la consolidation des actions.

Trading on a Consolidated Basis/Négociation sur une Base Consolidée : Le 21 mars/March 2024
Record Date/Date d'Enregistrement : Le 22 mars/March 2024
Anticipated Payment Date/Date de Paiement Prévue : Le 22 mars/March 2024
Symbol/Symbole : NARA
NEW/NOUVEAU CUSIP : 69842E 30 4
NEW/NOUVEAU ISIN : CA 69842E 30 4 1
Old/Vieux CUSIP & ISIN : 69842E205/CA69842E2050

If you have any questions or require further information please contact Listings at (416) 367-7340 or E-mail: Listings@thecse.com.

Pour toute question ou information complémentaire, veuillez contacter Listings au 416 367-7340 ou par courriel à: Listings@thecse.com.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment